BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
1-Year Return
64.18%
This Quarter Return
+9.48%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$297M
AUM Growth
+$42M
(+17%)
Cap. Flow
+$36.7M
Cap. Flow
% of AUM
12.37%
Top 10 Holdings %
Top 10 Hldgs %
53.44%
Holding
31
New
13
Increased
3
Reduced
7
Closed
8
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$18.9M |
| 2 |
ENDP
Endo International plc
ENDP
|
$15.6M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$15M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$12.8M |
| 5 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$12.6M |
Top Sells
| 1 |
Incyte
INCY
|
$16M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$14.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$14.1M |
| 4 |
NUVA
NuVasive, Inc.
NUVA
|
$13.7M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.9M |
Sector Composition
| 1 | Healthcare | 82.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.2B
| – | – |
-473,008
| Closed | -$12.8M |
|
|
27
Incyte
INCY
$16.9B
| – | – |
-144,710
| Closed | -$16M |
|
28
Nektar Therapeutics
NKTR
$764M
| – | – |
-73,333
| Closed | -$12.1M |
|
|
NUVA
29
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-285,000
| Closed | -$13.7M |
|
|
ALXN
30
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-89,884
| Closed | -$14.1M |
|
|
WCG
31
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-150,000
| Closed | -$12.9M |
|